Bristol-Myers Squibb Co (BMY)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

430 E. 29TH STREET NEW YORK, NY 10016

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other healthcare-related products. The Company has three segments: Pharmaceuticals, Nutritionals and ConvaTec. The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business. The other two segments Nutritionals and ConvaTec comprise the Company's Health Care Group. The Nutritionals segment consists of Mead Johnson Nutritionals (Mead Johnson), primarily an infant formula and children's nutritionals business. The ConvaTec segment consists of the ostomy, wound and skin care business.

Data based on most recent fiscal year report
Market Cap102.736 Billion Shares Outstanding1.637 Billion Avg Volume12.73 Million
1-Yr BETA vs S&P TR Current Ratio1.55 Quick Ratio1.43
View SEC Filings from BMY instead.
Q4 2018 All Institutions Hedge Funds 1
To trade BMY now:
Filers who had this stock in their top 10: 37 7 (0.7%)
13F Filers holding this stock: 1655 130 (13.0%)
Aggregate 13F shares on 12/31/2018: 1.192 Billion 80.816 Million
Aggregate 13F shares on 09/30/2018: 1.187 Billion 73.418 Million
Percent change: 0.47% 10.08%
Funds creating new positions: 180 21
Funds Adding to an existing position: 524 44
Funds closing out their position: 148 17
Funds reducing their position: 712 48
Heat Map Ranking for 09/30/2018 103
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BMY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to

Exclude:

Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

4.5 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WILLIAMS R SANDERS

  • Director
7,886 2019-02-12 0

BOERNER CHRISTOPHER S. EVP, CHIEF COMMERCIAL OFFICER

  • Officer
2,874 2019-02-02 2

GROBSTEIN MICHAEL

  • Director
0 2019-02-01 5

STORCH GERALD L

  • Director
0 2019-02-01 5

SATO VICKI L

  • Director
0 2019-02-01 1

LACY ALAN J

  • Director
0 2019-02-01 5

PALIWAL DINESH C

  • Director
0 2019-02-01 7

ARDUINI PETER J

  • Director
0 2019-02-01 5

SAMUELS THEODORE R. II

  • Director
0 2019-02-01 5

EMMENS MATTHEW

  • Director
0 2019-02-01 5

BERTOLINI ROBERT J

  • Director
0 2019-02-01 5

VOUSDEN KAREN H

  • Director
0 2019-02-01 5

CELENTANO JOHN E

  • Director
0 2019-01-02 0

GLIMCHER LAURIE H M.D.

  • Director
7,285 2019-01-02 0

JOHANSSON LEIF

  • Director
0 2018-12-06 0

BANCROFT CHARLES A EVP & CHIEF FINANCIAL OFFICER

  • Officer
339,806 2018-12-02 4

GORDON MURDO EVP GLOBAL COMMERCIAL OPS

  • Officer
34,213 2018-11-02 2

BIONDI PAUL SVP, HEAD OF STRATEGY & BD

  • Officer
300 2018-10-02 3

BASELGA JOSE

  • Director
No longer subject to file 2018-09-30 5

STORCH GERALD L

STORCH GERALD L

  • Director
0 2018-09-30 5

ANDREOTTI LAMBERTO

  • Director
21,656 2018-09-14 0

DUBOW ADAM CHIEF COMPLIANCE & ETHICS OFFI

  • Officer
15,222 2018-09-03 2

SANTIAGO KAREN MURPHY CONTROLLER

  • Officer
3,837 2018-09-01 2

CUSS FRANCIS M

  • Director
10,000 2018-07-20 0

SIGAL ELLIOT

  • Director
12,714 2018-05-30 0

ROBINSON JAMES D III

  • Director
  • 10% Owner
8,710,679 2018-05-29 0

CAFORIO GIOVANNI CHAIRMAN AND CEO

  • Officer
  • Director
288,033 2018-05-05 2

HOOPER ANTHONY C EVP, GLOBAL COMMERCIAL OPS.

  • Officer
215,147 2018-05-03 0

LYNCH THOMAS J. JR. EVP & CHIEF SCIENTIFIC OFFICER

  • Officer
15,479 2018-04-03 2

SCHMUKLER LOUIS S PRES., GLOBAL MFG. & SUPPLY

  • Officer
42,831 2018-03-10 1

LEUNG SANDRA EVP, GENERAL COUNSEL

  • Officer
470,599 2018-03-10 1

VON AUTENRIED PAUL SVP, ENTERP. SERVICES & CIO

  • Officer
125,264 2018-03-10 1

ELICKER JOHN E SVP, PUBLIC AFFAIRS & IR

  • Officer
80,968 2018-03-10 1

JUDGE ANN POWELL SVP, GLOBAL HUMAN RESOURCES

  • Officer
62,749 2018-03-10 1

LEVIN JEREMY M CEO

  • Officer
  • Director
  • 10% Owner
0 2018-01-19 0

HELLER FRANCES K

  • Director
47,961 2017-10-13 0

CALDARELLA JOSEPH C SVP & CONTROLLER

  • Officer
48,076 2017-09-06 0

NIELSEN ANNE CHIEF COMPLIANCE & ETHICS OFF

  • Officer
37,974 2017-09-03 0

CORNELIUS JAMES M

  • Director
No longer subject to file 2017-06-15 0

WEST TOGO D JR

  • Director
0 2017-04-06 0

BLIN EMMANUEL SVP, CHIEF STRATEGY OFFICER

  • Officer
20,138 2017-03-10 0

CAMPBELL LEWIS B

  • Director
2,110 2016-03-08 0

MOED SAMUEL J SVP, STRAT PLAN & ANALYSIS

  • Officer
31,615 2015-03-13 0

DANIELS BRIAN SVP GLOBAL DEV & MED AFFAIRS

  • Officer
No longer subject to file 2014-07-01 0

CAZALA BEATRICE J EVP COMMERCIAL OPERATIONS

  • Officer
177,118 2013-05-31 0

FREEH LOUIS J

  • Director
0 2013-02-01 0

CARLO DE NOTARISTEFANI PRES TECH OPS & SUPP FNCTNS

  • Officer
8,432 2011-06-14 0

ZITO ROBERT T SVP & CHIEF COMM OFFICER

  • Officer
35,469 2010-03-06 0

MCBRIDE ANTHONY A SVP HUMAN RESOURCES

  • Officer
34,292 2010-03-06 0

HUET JEAN-MARC EVP & CFO

  • Officer
25,000 2009-04-30 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

BOERNER CHRISTOPHER S. - Officer EVP, CHIEF COMMERCIAL OFFICER

2019-02-02 M 4,465 a 4,465 2,874.00 direct

BOERNER CHRISTOPHER S. - Officer EVP, CHIEF COMMERCIAL OFFICER

2019-02-02 M 4,465 d 0 2,874.00 direct

BOERNER CHRISTOPHER S. - Officer EVP, CHIEF COMMERCIAL OFFICER

2019-02-02 F 1,591 $49.89 d 2,874 2,874.00 direct

ARDUINI PETER J - Director

2019-02-01 A 3,708 $49.89 a 18,792 0.00 direct

LACY ALAN J - Director

2019-02-01 A 3,708 $49.89 a 69,837 0.00 direct

VOUSDEN KAREN H - Director

2019-02-01 A 3,708 $49.89 a 7,525 0.00 direct

SATO VICKI L - Director

2019-02-01 A 3,708 $49.89 a 65,318 0.00 direct

STORCH GERALD L - Director

2019-02-01 A 3,708 $49.89 a 48,819 0.00 direct

PALIWAL DINESH C - Director

2019-02-01 A 3,708 $49.89 a 26,500 0.00 direct

BERTOLINI ROBERT J - Director

2019-02-01 A 3,708 $49.89 a 13,891 0.00 direct

GROBSTEIN MICHAEL - Director

2019-02-01 A 3,708 $49.89 a 79,808 0.00 direct

EMMENS MATTHEW - Director

2019-02-01 A 3,708 $49.89 a 13,989 0.00 direct

SAMUELS THEODORE R. II - Director

2019-02-01 A 3,708 $49.89 a 12,885 0.00 direct

STORCH GERALD L - Director

2018-12-31 A 625 $51.98 a 44,119 0.00 direct

EMMENS MATTHEW - Director

2018-12-31 A 625 $51.98 a 10,064 0.00 direct

SAMUELS THEODORE R. II - Director

2018-12-31 A 589 $51.98 a 8,984 0.00 direct

VOUSDEN KAREN H - Director

2018-12-31 A 150 $51.98 a 3,735 0.00 direct

BERTOLINI ROBERT J - Director

2018-12-31 A 637 $51.98 a 9,969 0.00 direct

LACY ALAN J - Director

2018-12-31 A 589 $51.98 a 64,668 0.00 direct

ARDUINI PETER J - Director

2018-12-31 A 625 $51.98 a 14,761 0.00 direct

PALIWAL DINESH C - Director

2018-12-31 A 589 $51.98 a 22,296 0.00 direct

GROBSTEIN MICHAEL - Director

2018-12-31 A 337 $51.98 a 74,412 0.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments